77 related articles for article (PubMed ID: 7296970)
1. Effect of antihypertensive therapy on plasma catecholamines in renal failure patients.
Henrich WL; Mitchell H; Anderson S; Cronin R; Pettinger WA
Clin Nephrol; 1981 Sep; 16(3):131-6. PubMed ID: 7296970
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma norepinephrine and sympathetic nervous activity in essential hypertensive and uremic humans: effects of clonidine.
Izzo JL; Santarosa RP; Larrabee PS; Smith RJ; Kallay MC
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S225-9. PubMed ID: 2455184
[TBL] [Abstract][Full Text] [Related]
3. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
Svarstad E; Myking O; Ofstad J; Iversen BM
Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid norepinephrine levels in essential hypertension: effects of drug treatment and withdrawal.
Cubeddu LX; Hoffman IS
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S205-10. PubMed ID: 2455180
[TBL] [Abstract][Full Text] [Related]
5. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
[TBL] [Abstract][Full Text] [Related]
6. [Arterial hypertension in patients on chronic hemodialysis].
Zogović J; Mladenović Lj
Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
[TBL] [Abstract][Full Text] [Related]
7. Plasma catecholamine levels in normal subjects and in patients with secondary hypertension.
Lake CR; Chernow B; Goldstein DS; Glass DG; Coleman M; Ziegler MG
Fed Proc; 1984 Jan; 43(1):52-6. PubMed ID: 6690338
[TBL] [Abstract][Full Text] [Related]
8. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
Ishimitsu T; Nishikimi T; Saito Y; Kitamura K; Eto T; Kangawa K; Matsuo H; Omae T; Matsuoka H
J Clin Invest; 1994 Nov; 94(5):2158-61. PubMed ID: 7962564
[TBL] [Abstract][Full Text] [Related]
11. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
12. The relationship between potassium balance and circulating catecholamines in essential hypertension.
Cerasola G; Morici ML; Cottone S; Grasso L; D'Ignoto G
Boll Soc Ital Biol Sper; 1984 Jun; 60(6):1111-7. PubMed ID: 6477727
[TBL] [Abstract][Full Text] [Related]
13. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
[TBL] [Abstract][Full Text] [Related]
14. [Increased adrenomedullin levels in hypertensive patients on maintenance hemodialysis].
Cases A; Esforzado N; Vera M; Lario S; López-Pedret J; Jiménez W; Rivera-Fillat F
Nefrologia; 2000; 20(5):424-30. PubMed ID: 11100663
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between regional sympathetic activity and the onset of arterial hypertension in spontaneously hypertensive rats].
Cabassi A; Vinci S; Calzolari M; Bruschi G; Cavatorta A; Borghetti A
Cardiologia; 1997 Apr; 42(4):393-6. PubMed ID: 9244643
[TBL] [Abstract][Full Text] [Related]
16. Untoward effects of chronic dual renin-angiotensin system blockade: influence of previous chronic renal failure.
Robles NR; Cancho B; Barroso S; Martín MV; Sánchez Casado E
Int J Clin Pract; 2006 Sep; 60(9):1035-9. PubMed ID: 16939543
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
[TBL] [Abstract][Full Text] [Related]
18. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
[TBL] [Abstract][Full Text] [Related]
19. Sympathetic nervous system overactivity in hypertensive patients with chronic renal failure--role of upright body position.
Svarstad E; Myking O; Ofstad J; Iversen BM
Scand J Urol Nephrol; 2001 Oct; 35(5):393-400. PubMed ID: 11771867
[TBL] [Abstract][Full Text] [Related]
20. [Lercanidipine in diabetic patients with renal failure].
Robles NR; Pastor L; Manjón M; Ocón J; Gómez Campderá F; Herrera J; Villatoro J; Calls J; Torrijos J; Rodríguez Villareal I; Rodríguez Martínez MA; Méndez ML; Morey A; Martínez Fernández J; Marco J; Liébana A; Rincón B; Tornero F
Nefrologia; 2004; 24(4):338-43. PubMed ID: 15455493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
